Author

Sarah Robertson

Primary ORCID profile (0000-0002-4936-5065 · 1 paper)Unclaimed ORCID profile · follow to get notified of new preprints

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Same name, identified by ORCID

Sarah RobertsoniD1 paper · University of Maryland, College Park

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1 Organism:mouse· 1

Frequent Co-Authors

Anthony Bosco· 1 shared Anya Jones· 1 shared Christian Pasquali· 1 shared Deborah Strickland· 1 shared Jeff Lauzon-Joset· 1 shared Jonatan Leffler· 1 shared Kyle Mincham· 1 shared Michael SerralhaiD· 1 shared

Activity by Year

2017-2017 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

Anthony Bosco

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Protection against maternal infection-associated fetal growth restriction - proof-of-concept with a microbial-derived immunomodulator OM85: safety and efficacy data

Naomi Scott, Jeff Lauzon-Joset, Anya Jones, Kyle Mincham, Niamh Troy, Jonatan Leffler, Michael Serralha, Susan Prescott, Sarah Robertson, Christian Pasquali, Anthony Bosco, Patrick Holt, Deborah Strickland

This study shows that OM85, an immunomodulator, reduces fetal loss and growth restriction in pregnant mice exposed to bacterial LPS or influenza, by modulating maternal inflammatory responses without impairing anti-microbial defenses.

Mucosal Immunology · May 1, 2017Peer-reviewedImmunology